Physicians must figure out how to get CRISPR into the tissues that are most affected by a given disease. In addition, this must be accomplished without provoking an immune response in the patients’ bodies. Furthermore, Cas9 and its RNA guide will have to be stable enough to survive inside the body until editing is completed.
